Rachlis Beth, Cole Donald C, van Lettow Monique, Escobar Michael, Muula Adamson S, Ahmad Farah, Orbinski James, Chan Adrienne K
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada; Dignitas International, Zomba, Malawi.
PLoS One. 2014 Jul 17;9(7):e101875. doi: 10.1371/journal.pone.0101875. eCollection 2014.
Identifying follow-up (FU) visit patterns, and exploring which factors influence them are likely to be useful in determining which patients on antiretroviral therapy (ART) may become Lost to Follow-Up (LTFU). Using an operation and implementation research approach, we sought 1) to describe the timing of FU visits amongst patients who have been on ART for shorter and longer periods of time; and 2) to determine the median time to late visits, and 3) to identify specific factors that may be associated with these patterns in Zomba, Malawi.
Using routinely collected programme monitoring data from Zomba District, we performed descriptive analyses on all ART visits among patients who initiated ART between Jan. 1, 2007-June 30, 2010. Based on an expected FU date, each FU visit was classified as early (≥4 day before an expected FU date), on time (3 days before an expected FU date/up to 6 days after an expected FU date), or late (≥7 days after an expected FU date). In total, 7,815 patients with 76417 FU visits were included. Ninety-two percent of patients had ≥2 FU visits. At the majority of visits, patients were either on time or late. The median time to a first late visit among those with 2 or more visits was 216 days (IQR: 128-359). Various patient- and visit-level factors differed significantly across Early, On Time, and Late visit groups including ART adherence and frequency of, and type of side effects.
The majority of patients do not demonstrate consistent FU visit patterns. Individuals were generally on ART for at least 6 months before experiencing their first late visit. Our findings have implications for the development of effective interventions that meet patient needs when they present early and can reduce patient losses to follow-up when they are late. In particular, time-varying visit characteristics need further research.
识别随访(FU)就诊模式,并探究哪些因素对其产生影响,这可能有助于确定哪些接受抗逆转录病毒治疗(ART)的患者可能会失访(LTFU)。我们采用运营与实施研究方法,旨在:1)描述接受ART治疗时间较短和较长的患者的FU就诊时间;2)确定首次迟到就诊的中位时间;3)识别马拉维松巴地区可能与这些模式相关的具体因素。
我们使用从松巴地区常规收集的项目监测数据,对2007年1月1日至2010年6月30日开始接受ART治疗的患者的所有ART就诊进行描述性分析。根据预期的FU日期,每次FU就诊被分类为提前(预期FU日期前≥4天)、准时(预期FU日期前3天/预期FU日期后最多6天)或迟到(预期FU日期后≥7天)。总共纳入了7815名患者的76417次FU就诊。92%的患者有≥2次FU就诊。在大多数就诊中,患者要么准时就诊,要么迟到就诊。有2次或更多次就诊的患者中,首次迟到就诊的中位时间为216天(四分位间距:128 - 359)。不同的患者和就诊层面因素在提前、准时和迟到就诊组之间存在显著差异,包括ART依从性、副作用的频率和类型。
大多数患者没有表现出一致的FU就诊模式。个体通常在接受ART治疗至少6个月后才首次出现迟到就诊。我们的研究结果对于制定有效的干预措施具有启示意义,这些措施可以在患者提前就诊时满足其需求,并在患者迟到就诊时减少失访情况。特别是,随时间变化的就诊特征需要进一步研究。